zaurategrast   Click here for help

GtoPdb Ligand ID: 11488

Synonyms: CDP-323 | CDP323
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Zaurategrast (CDP-323) is a small molecule inhibitor of α4-containing integrin complexes that was developed by Celltech [3]. It was intended as a new oral drug treatment for multiple sclerosis [2]. Zaurategrast has the same mechanism of action as the approved MS therapeutic natalizumab. Zaurategrast is an ester prodrug whose active entity is CT7758 [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 7
Topological polar surface area 104.21
Molecular weight 520.11
XLogP 2.64
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES OC(=O)[C@@H](NC1=C(Br)C(=O)C21CCCCC2)Cc1ccc(cc1)Nc1nccc2c1cncc2
Isomeric SMILES OC(=O)[C@@H](NC1=C(Br)C(=O)C21CCCCC2)Cc1ccc(cc1)Nc1nccc2c1cncc2
InChI InChI=1S/C26H25BrN4O3/c27-21-22(26(23(21)32)10-2-1-3-11-26)31-20(25(33)34)14-16-4-6-18(7-5-16)30-24-19-15-28-12-8-17(19)9-13-29-24/h4-9,12-13,15,20,31H,1-3,10-11,14H2,(H,29,30)(H,33,34)/t20-/m0/s1
1. Chanteux H, Staelens L, Mancel V, Gerin B, Boucaut D, Prakash C, Nicolas JM. (2015)
Cross-Species Differences in the Preclinical Pharmacokinetics of CT7758, an α4β1/α4β7 Integrin Antagonist.
Drug Metab Dispos, 43 (9): 1381-91. [PMID:26153275]
2. Davenport RJ, Munday JR. (2007)
Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?.
Drug Discov Today, 12 (13-14): 569-76. [PMID:17631252]
3. Li H, Huang SY, Shi FH, Gu ZC, Zhang SG, Wei JF. (2018)
α4β7 integrin inhibitors: a patent review.
Expert Opin Ther Pat, 28 (12): 903-917. [PMID:30444683]
4. Wolf C, Sidhu J, Otoul C, Morris DL, Cnops J, Taubel J, Bennett B. (2013)
Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study.
PLoS One, 8 (3): e58438. [PMID:23472197]